I know what you mean. ...
One thing that seemed to get missed or not mentioned at the last update was the relevance of the patent application for glaucoma .....
My simple thought is that the approach / methodology that is being used in the eye programs has allowed them to discover that if it proves effective in the current trials, then the same approach would be effective in glaucoma. If that was the case then that surely opens up a huge opportunity. Or am I just being overly optimistic.
I know what you mean . ... One thing that seemed to get missed...
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $513.2M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 11.0¢ | $13.75K | 125.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 243340 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 47818 | 4 |
View Market Depth
| Last trade - 10.17am 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.0¢ |
Change
0.000 ( 0.36 %) |
||||
| Open | High | Low | Volume | ||
| 11.0¢ | 11.0¢ | 11.0¢ | 7323 | ||
| Last updated 10.38am 07/05/2024 ? | |||||
| PYC (ASX) Chart |